Redwood Scientific Technologies, Inc.
RSCIOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1872
P/E Ratio—
52W High$0.07
52W Low$0.0001
Redwood Scientific Technologies, Inc. (RSCI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RSCI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2020-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Gross Margin %(computed) | — | — | — | 73.63% | 57.74% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Operating Margin %(computed) | — | — | — | 3.99% | -9.94% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Net Margin %(computed) | — | — | — | 1.21% | -19.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.00 | $-0.00 | $0.55 | $-6.02 |
| Wtd Avg Shares | 0.19B | 0.18B | 0.18B | 0.17B | 0.17B |
| EBITDA | ($0.00B) | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | 3.06% | -18.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Redwood Scientific Technologies, Inc. data
About Redwood Scientific Technologies, Inc. (RSCI) Income Statement
Redwood Scientific Technologies, Inc. (RSCI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, RSCI reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
RSCI · 4 questionsRedwood Scientific Technologies, Inc. (RSCI) reported revenue of $0.00B for 2023, down —% year-over-year.
RSCI revenueRSCI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09